UniSuper Management Pty Ltd Buys 2,588 Shares of Waters Corporation $WAT

UniSuper Management Pty Ltd raised its position in Waters Corporation (NYSE:WAT) by 37.0% during the third quarter, according to its most recent 13F filing with the SEC. The fund owned 9,592 shares of the medical instruments supplier’s stock after buying an additional 2,588 shares during the period. UniSuper Management Pty Ltd’s holdings in Waters were worth $2,876,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds also recently made changes to their positions in the company. Root Financial Partners LLC bought a new position in Waters in the third quarter valued at about $26,000. IFP Advisors Inc boosted its stake in shares of Waters by 65.4% in the 2nd quarter. IFP Advisors Inc now owns 134 shares of the medical instruments supplier’s stock valued at $51,000 after purchasing an additional 53 shares during the last quarter. CYBER HORNET ETFs LLC bought a new stake in shares of Waters during the second quarter worth approximately $53,000. Versant Capital Management Inc lifted its holdings in Waters by 510.3% in the third quarter. Versant Capital Management Inc now owns 177 shares of the medical instruments supplier’s stock valued at $53,000 after buying an additional 148 shares during the period. Finally, Quent Capital LLC bought a new position in Waters in the third quarter valued at approximately $59,000. Institutional investors own 94.01% of the company’s stock.

Waters Trading Down 0.3%

NYSE:WAT opened at $391.24 on Tuesday. The company has a debt-to-equity ratio of 0.41, a current ratio of 1.53 and a quick ratio of 1.08. The business’s 50-day simple moving average is $390.58 and its 200-day simple moving average is $342.14. Waters Corporation has a fifty-two week low of $275.05 and a fifty-two week high of $423.56. The stock has a market capitalization of $23.30 billion, a PE ratio of 35.96, a price-to-earnings-growth ratio of 3.28 and a beta of 1.16.

Waters (NYSE:WAT) last announced its quarterly earnings results on Tuesday, November 4th. The medical instruments supplier reported $3.40 earnings per share for the quarter, beating analysts’ consensus estimates of $3.21 by $0.19. Waters had a net margin of 20.89% and a return on equity of 36.59%. The firm had revenue of $799.89 million for the quarter, compared to analyst estimates of $780.05 million. During the same quarter in the previous year, the firm posted $2.93 earnings per share. The business’s revenue was up 8.1% on a year-over-year basis. Waters has set its FY 2025 guidance at 13.050-13.150 EPS and its Q4 2025 guidance at 4.450-4.550 EPS. Sell-side analysts expect that Waters Corporation will post 12.86 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of research firms have recently weighed in on WAT. Wells Fargo & Company increased their price target on Waters from $385.00 to $415.00 and gave the company an “equal weight” rating in a research note on Monday, December 15th. Weiss Ratings restated a “hold (c)” rating on shares of Waters in a report on Wednesday, January 21st. Rothschild & Co Redburn started coverage on Waters in a research report on Wednesday, October 8th. They set a “buy” rating and a $390.00 target price for the company. Morgan Stanley started coverage on shares of Waters in a research note on Monday, December 1st. They set an “equal weight” rating and a $423.00 price objective on the stock. Finally, Guggenheim assumed coverage on shares of Waters in a research note on Tuesday, January 6th. They issued a “buy” rating and a $440.00 target price for the company. One analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating and nine have given a Hold rating to the stock. According to data from MarketBeat, Waters presently has an average rating of “Moderate Buy” and a consensus target price of $395.00.

Waters Company Profile

Waters Corporation is a global provider of analytical instruments, software and services for laboratory and research applications. The company designs, manufactures and sells technologies centered on liquid chromatography, mass spectrometry, separation science, and related sample preparation and detection systems. Its product portfolio includes chromatographs, mass spectrometers, columns and consumables, laboratory informatics and workflow software, as well as technical support and training services that help customers run and interpret complex analyses.

Waters serves a wide range of end markets that include pharmaceutical and biotechnology companies, contract research and testing laboratories, academic and government research institutions, clinical diagnostics, food and environmental testing, and industrial and chemical manufacturers.